A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

A smooth scraper glides over a bed of mixed yellow round sand, creating delicate patterns ... in May Big Changes Are Coming To KFC In 2025 5 questions HR legally cannot ask you in a job interview ...

Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

Eli Lilly says its GLP-1 drug in pill form is as safe and effective as Ozempic and other mega-popular injectable drugs for weight loss and lowering blood sugar. The company announ ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

The drug manufacturer will no longer study and test danuglipron after a participant in a clinical trial was injured.

Hypervisibility is one factor contributing to its recent surge. Red carpet aside, butter yellow has quickly become a runway mainstay, spotted across a myriad of spring/summer 2025 shows—from ...

What’s in store for Round 2? Here are 5 things to know for Friday’s second round at the 2025 Masters. Justin Rose has never won a green jacket but he does have an excellent track record at ...

What’s in store for Round 2? Here are 5 things to know for Saturday’s third round at the 2025 Masters. On Friday, Justin Rose didn’t quite summon the magic of his opening-round 65 from ...